247 related articles for article (PubMed ID: 28611266)
21. IFN-α confers epigenetic regulation of HBV cccDNA minichromosome by modulating GCN5-mediated succinylation of histone H3K79 to clear HBV cccDNA.
Yuan Y; Yuan H; Yang G; Yun H; Zhao M; Liu Z; Zhao L; Geng Y; Liu L; Wang J; Zhang H; Wang Y; Zhang XD
Clin Epigenetics; 2020 Sep; 12(1):135. PubMed ID: 32894195
[TBL] [Abstract][Full Text] [Related]
22. Forkhead O Transcription Factor 4 Restricts HBV Covalently Closed Circular DNA Transcription and HBV Replication through Genetic Downregulation of Hepatocyte Nuclear Factor 4 Alpha and Epigenetic Suppression of Covalently Closed Circular DNA via Interacting with Promyelocytic Leukemia Protein.
Li Y; He M; Gong R; Wang Z; Lu L; Peng S; Duan Z; Feng Y; Liu Y; Gao B
J Virol; 2022 Jul; 96(13):e0054622. PubMed ID: 35695580
[TBL] [Abstract][Full Text] [Related]
23. Mapping of histone modifications in episomal HBV cccDNA uncovers an unusual chromatin organization amenable to epigenetic manipulation.
Tropberger P; Mercier A; Robinson M; Zhong W; Ganem DE; Holdorf M
Proc Natl Acad Sci U S A; 2015 Oct; 112(42):E5715-24. PubMed ID: 26438841
[TBL] [Abstract][Full Text] [Related]
24. SIRT3 restricts hepatitis B virus transcription and replication through epigenetic regulation of covalently closed circular DNA involving suppressor of variegation 3-9 homolog 1 and SET domain containing 1A histone methyltransferases.
Ren JH; Hu JL; Cheng ST; Yu HB; Wong VKW; Law BYK; Yang YF; Huang Y; Liu Y; Chen WX; Cai XF; Tang H; Hu Y; Zhang WL; Liu X; Long QX; Zhou L; Tao NN; Zhou HZ; Yang QX; Ren F; He L; Gong R; Huang AL; Chen J
Hepatology; 2018 Oct; 68(4):1260-1276. PubMed ID: 29624717
[TBL] [Abstract][Full Text] [Related]
25. Nuclear Sensor Interferon-Inducible Protein 16 Inhibits the Function of Hepatitis B Virus Covalently Closed Circular DNA by Integrating Innate Immune Activation and Epigenetic Suppression.
Yang Y; Zhao X; Wang Z; Shu W; Li L; Li Y; Guo Z; Gao B; Xiong S
Hepatology; 2020 Apr; 71(4):1154-1169. PubMed ID: 31402464
[TBL] [Abstract][Full Text] [Related]
26. HBx relieves chromatin-mediated transcriptional repression of hepatitis B viral cccDNA involving SETDB1 histone methyltransferase.
Rivière L; Gerossier L; Ducroux A; Dion S; Deng Q; Michel ML; Buendia MA; Hantz O; Neuveut C
J Hepatol; 2015 Nov; 63(5):1093-102. PubMed ID: 26143443
[TBL] [Abstract][Full Text] [Related]
27. Hepatitis B Virus Core Protein Is Not Required for Covalently Closed Circular DNA Transcriptional Regulation.
Zhong Y; Wu C; Xu Z; Teng Y; Zhao L; Zhao K; Wang J; Wang W; Zhan Q; Zhu C; Chen X; Liang K; Cheng X; Xia Y
J Virol; 2022 Nov; 96(21):e0136222. PubMed ID: 36226986
[TBL] [Abstract][Full Text] [Related]
28. The histone variant H3.3 regulates the transcription of the hepatitis B virus.
Alvarez-Astudillo F; Garrido D; Varas-Godoy M; Gutiérrez JL; Villanueva RA; Loyola A
Ann Hepatol; 2021; 21():100261. PubMed ID: 33007428
[TBL] [Abstract][Full Text] [Related]
29. Transcription of hepatitis B virus covalently closed circular DNA is regulated by CpG methylation during chronic infection.
Zhang Y; Mao R; Yan R; Cai D; Zhang Y; Zhu H; Kang Y; Liu H; Wang J; Qin Y; Huang Y; Guo H; Zhang J
PLoS One; 2014; 9(10):e110442. PubMed ID: 25337821
[TBL] [Abstract][Full Text] [Related]
30. Silencing hepatitis B virus covalently closed circular DNA: The potential of an epigenetic therapy approach.
Singh P; Kairuz D; Arbuthnot P; Bloom K
World J Gastroenterol; 2021 Jun; 27(23):3182-3207. PubMed ID: 34163105
[TBL] [Abstract][Full Text] [Related]
31. Hepatitis B virus cccDNA: Formation, regulation and therapeutic potential.
Xia Y; Guo H
Antiviral Res; 2020 Aug; 180():104824. PubMed ID: 32450266
[TBL] [Abstract][Full Text] [Related]
32. Cellular DNA Topoisomerases Are Required for the Synthesis of Hepatitis B Virus Covalently Closed Circular DNA.
Sheraz M; Cheng J; Tang L; Chang J; Guo JT
J Virol; 2019 Jun; 93(11):. PubMed ID: 30867306
[TBL] [Abstract][Full Text] [Related]
33. Establishment of Cre-mediated HBV recombinant cccDNA (rcccDNA) cell line for cccDNA biology and antiviral screening assays.
Wu M; Li J; Yue L; Bai L; Li Y; Chen J; Zhang X; Yuan Z
Antiviral Res; 2018 Apr; 152():45-52. PubMed ID: 29432776
[TBL] [Abstract][Full Text] [Related]
34. Parvulin 14 and Parvulin 17 Bind to HBx and cccDNA and Upregulate Hepatitis B Virus Replication from cccDNA to Virion in an HBx-Dependent Manner.
Saeed U; Kim J; Piracha ZZ; Kwon H; Jung J; Chwae YJ; Park S; Shin HJ; Kim K
J Virol; 2019 Mar; 93(6):. PubMed ID: 30567987
[TBL] [Abstract][Full Text] [Related]
35. IFN-α inhibits HBV transcription and replication in cell culture and in humanized mice by targeting the epigenetic regulation of the nuclear cccDNA minichromosome.
Belloni L; Allweiss L; Guerrieri F; Pediconi N; Volz T; Pollicino T; Petersen J; Raimondo G; Dandri M; Levrero M
J Clin Invest; 2012 Feb; 122(2):529-37. PubMed ID: 22251702
[TBL] [Abstract][Full Text] [Related]
36. HBV X protein mutations affect HBV transcription and association of histone-modifying enzymes with covalently closed circular DNA.
Chong CK; Cheng CYS; Tsoi SYJ; Huang FY; Liu F; Fung J; Seto WK; Lai KK; Lai CL; Yuen MF; Wong DK
Sci Rep; 2020 Jan; 10(1):802. PubMed ID: 31964944
[TBL] [Abstract][Full Text] [Related]
37. Silencing Retinoid X Receptor Alpha Expression Enhances Early-Stage Hepatitis B Virus Infection In Cell Cultures.
Song M; Sun Y; Tian J; He W; Xu G; Jing Z; Li W
J Virol; 2018 Apr; 92(8):. PubMed ID: 29437960
[TBL] [Abstract][Full Text] [Related]
38. DNA Polymerase alpha is essential for intracellular amplification of hepatitis B virus covalently closed circular DNA.
Tang L; Sheraz M; McGrane M; Chang J; Guo JT
PLoS Pathog; 2019 Apr; 15(4):e1007742. PubMed ID: 31026293
[TBL] [Abstract][Full Text] [Related]
39. Interferon Alpha Induces Multiple Cellular Proteins That Coordinately Suppress Hepadnaviral Covalently Closed Circular DNA Transcription.
Cheng J; Zhao Q; Zhou Y; Tang L; Sheraz M; Chang J; Guo JT
J Virol; 2020 Aug; 94(17):. PubMed ID: 32581092
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of HBV Transcription From cccDNA With Nitazoxanide by Targeting the HBx-DDB1 Interaction.
Sekiba K; Otsuka M; Ohno M; Yamagami M; Kishikawa T; Suzuki T; Ishibashi R; Seimiya T; Tanaka E; Koike K
Cell Mol Gastroenterol Hepatol; 2019; 7(2):297-312. PubMed ID: 30704981
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
